Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
49
SIBN Quote, Financials, Valuation and Earnings
Last price:
$20.38
Seasonality move
:
-2.46%
Day range:
$20.02 - $20.74
52-week range:
$12.50 - $21.07
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.48x
P/B ratio:
5.13x
Volume:
123.1K
Avg. volume:
579K
1-year change:
53.43%
Market cap:
$883.4M
Revenue:
$167.2M
EPS (TTM):
-$0.51
Analysts' Opinion
-
Consensus RatingSI-BONE, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $25.89, SI-BONE, Inc. has an estimated upside of 27.16% from its current price of $20.36.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $23.00 representing 100% downside risk from its current price of $20.36.
Fair Value
-
According to the consensus of 5 analysts, SI-BONE, Inc. has 27.16% upside to fair value with a price target of $25.89 per share.
SIBN vs. S&P 500
-
Over the past 5 trading days, SI-BONE, Inc. has overperformed the S&P 500 by 4.88% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
SI-BONE, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
SI-BONE, Inc. has grown year-over-year revenues for 21 quarters straight. In the most recent quarter SI-BONE, Inc. reported revenues of $48.7M.
Earnings Growth
-
SI-BONE, Inc. has grown year-over-year earnings for 13 quarters straight. In the most recent quarter SI-BONE, Inc. reported earnings per share of -$0.11.
Enterprise value:
774.5M
EV / Invested capital:
3.71x
Price / LTM sales:
4.48x
EV / EBIT:
--
EV / Revenue:
4.00x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-72.95x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$154.1M
Return On Assets:
-9.46%
Net Income Margin (TTM):
-11.24%
Return On Equity:
-12.92%
Return On Invested Capital:
-10.56%
Operating Margin:
-11.06%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $132M | $157M | $193.6M | $40.3M | $48.7M | |
| Gross Profit | $107.6M | $122M | $154.1M | $31.9M | $38.8M | |
| Operating Income | -$45.7M | -$42.3M | -$25.4M | -$7.6M | -$5.4M | |
| EBITDA | -$40.9M | -$37.5M | -$20M | -$6.5M | -$3.9M | |
| Diluted EPS | -$1.19 | -$0.91 | -$0.51 | -$0.16 | -$0.11 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $185.6M | $139.2M | $211M | $203.7M | $210.8M | |
| Total Assets | $194M | $158.3M | $230.9M | $227M | $234.3M | |
| Current Liabilities | $14.6M | $18.6M | $19.4M | $24.7M | $26.4M | |
| Total Liabilities | $50.3M | $55.4M | $57.3M | $62M | $62.1M | |
| Total Equity | $143.6M | $102.8M | $173.6M | $165M | $172.1M | |
| Total Debt | $34.9M | $38.3M | $37.9M | $37.3M | $35.7M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$23.2M | -$15.9M | -$1.2M | $302K | $2.3M | |
| Cash From Investing | -$40.8M | -$10.6M | -$4.5M | $3.8M | -$10M | |
| Cash From Financing | $90.8M | $2.9M | $2.3M | $155K | $11K | |
| Free Cash Flow | -$31.6M | -$25.2M | -$10.6M | -$2.7M | -$620K | |
SIBN
Sector
Market Cap
$883.4M
$28M
Price % of 52-Week High
96.63%
51.03%
Dividend Yield
0%
0%
Shareholder Yield
-0.38%
-1.54%
1-Year Price Total Return
53.43%
-17.48%
Beta (5-Year)
0.756
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$19.90
200-day SMA
Buy
Level
$16.55
Bollinger Bands (100)
Buy
Level
14.69 - 18.41
Chaikin Money Flow
Buy
Level
343.4K
20-day SMA
Buy
Level
$19.43
Relative Strength Index (RSI14)
Buy
Level
64.07
ADX Line
Buy
Level
32.77
Williams %R
Neutral
Level
-26.0073
50-day SMA
Buy
Level
$17.66
MACD (12, 26)
Buy
Level
5.36
25-day Aroon Oscillator
Buy
Level
88
On Balance Volume
Neutral
Level
1.1M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.1184)
Buy
CA Score
(Annual)
Level (0.1851)
Buy
Beneish M-Score
(Annual)
Level (-2.621)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (0.0871)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
SI-BONE, Inc. is a medical device company, which engages in the provision of a proprietary minimally invasive surgical implant system to fuse the sacroiliac joint for treatment of musculoskeletal disorders of the sacropelvic anatomy. It offers a proprietary minimally invasive surgical implant system, called iFuse, used to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 18, 2008 and is headquartered in Santa Clara, CA.
Stock Forecast FAQ
In the current month, SIBN has received 5 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SIBN average analyst price target in the past 3 months is $25.89.
-
Where Will SI-BONE, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that SI-BONE, Inc. share price will rise to $25.89 per share over the next 12 months.
-
What Do Analysts Say About SI-BONE, Inc.?
Analysts are divided on their view about SI-BONE, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that SI-BONE, Inc. is a Sell and believe this share price will drop from its current level to $23.00.
-
What Is SI-BONE, Inc.'s Price Target?
The price target for SI-BONE, Inc. over the next 1-year time period is forecast to be $25.89 according to 5 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is SIBN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for SI-BONE, Inc. is a Buy. 5 of 5 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of SIBN?
You can purchase shares of SI-BONE, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase SI-BONE, Inc. shares.
-
What Is The SI-BONE, Inc. Share Price Today?
SI-BONE, Inc. was last trading at $20.38 per share. This represents the most recent stock quote for SI-BONE, Inc.. Yesterday, SI-BONE, Inc. closed at $20.36 per share.
-
How To Buy SI-BONE, Inc. Stock Online?
In order to purchase SI-BONE, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get SIBN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SIBN
Sector
P/E ratio
--
23.89x
PEG ratio
--
-0.01x
P/B ratio
5.13x
1.82x
Price / LTM sales
4.48x
1.60x
Growth Metrics
SIBN
Sector
Revenue growth
20.62%
4.62%
Earnings growth
32.93%
10.88%
Revenue (5-year growth)
19.96%
6.5%
Earnings forecast
-$0.17
-$0.21
Profitability
SIBN
Sector
Profitability FY 2024
$132.1M
$3.5M
Return on invested capital
-10.56%
-31.77%
Return on assets
-9.46%
-27.96%
Return on equity
-12.92%
-37.63%
Earnings Date
Last Earnings Date
Nov
10
Next Earnings Date
Feb
23
Estimated Next Earnings Date
Feb
9
Balance Sheet
SIBN
Sector
Total cash
$145.7M
$26.3M
Short term investments
$115.1M
$25.7M
Total assets
$230.4M
$78M
Long term debt
$35.7M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
